Rebekah N. Plowman

Rebekah is a partner in the Healthcare practice and member of the Hospitals & Health Systems and Post-Acute & Long Term Care industry teams. In addition to her particular focus on government investigations, she is an essential resource for healthcare regulatory legal issues to hospitals and health systems, hospice, home health and other post-acute care providers, diagnostic imaging, ambulance and other suppliers, device manufactures, private investors, and other institutions that invest in or support the healthcare industry. Her practice encompasses fraud and abuse analysis, compliance program development and implementation, and corporate governance, including corporate integrity agreements (CIAs). She also conducts due diligence reviews associated with health care company acquisitions.

Rebekah has a particular focus handling extensive civil False Claims Act litigation brought by federal and state governmental agencies and whistleblowers. She navigates government enforcement actions involving Officer of Inspector General (OIG) civil monetary penalties, exclusion actions and State Attorney General (AG) and Medical Fraud Control Units (MFCU). Her False Claims Act and qui tam experience includes all types of billing, coding and medical necessity cases, as well as kickbacks and quality of care. She also defends providers in government audits and appeals, including program integrity contractor investigations (ZPIC/UPIC), Medicare Administrative Contractors (MAC), and state fraud units, as well as before The Joint Commission.

Prior to practicing law, Rebekah was a registered nurse in the Cardiac Intensive Care Unit at Indiana University Medical Center. Her experience as a provider to patients and a healthcare lawyer gives Rebekah a unique perspective that clients value. Harnessing her varied experience, Rebekah is an active writer and speaker on healthcare industry litigation, and fraud and abuse issues.

• FAQs Continue to Provide Additional Guidance for Providers Evaluating the Retention of CARES Act Provider Relief Funds: The Question of Materiality and the Importance of Recordkeeping and Corporate Documentation
• Should You Keep the Medicare Provider Relief Funds and If So, What are the Compliance Risks?
• HHS Issues New Guidance on PREP Act Immunity When Prescribing, Administering, or Dispensing Drugs and Devices for COVID-19
• Updated COVID-19 EMTALA Guidance for Hospitals with Dedicated Emergency Departments
• Secretary Azar Issues Guidance for Hospitals on COVID-19 Test Reporting
• CMS Issues Updated COVID-19 Infection Control Guidance for Various Inpatient and Outpatient Settings
• OIG Announces Anti-Kickback Enforcement Discretion in Response to Certain Stark Waivers Issued in Response to COVID-19 and Not Others
• CMS Waives Certain Medicare Physician Supervision Requirements to Afford Practitioners Greater Flexibility During COVID-19
• COVID-19 Spurs Government Action Through Multiple Temporary Regulatory Waivers for Health Care Providers